2011 First Quarter Plays

[millionaire]

MNKD is too much of one product play.
i think, they will lose.Not being accepted.

do not bet on CTIC. very strange co, too many shares.

[chibs]

who knows about IGNT? any prospect for this biotech

[hfsboatr]

Shorts working CTIC very hard and unable to bring price down. Increase in short position might indicate failed drug, but FDA does not issue orphan drug carelessly. This will trend higher as Advisory Comm. meets 2/10 and recommends approval. Shorts will now be forced to begin to cover, resulting in sporadic up ticks in price. 4/23 FDA approval appears likely. May I ask what is very strange about this company?

[Spunk]

DDSS moving towards intended target

up %9 today. hope this continues

[hfsboatr]

who's intended target, and what is it?

[globalequitygroup]

Good Call on the DDSS Spunk.

Comtex sees it continuing its bullish pattern.

Small Cap Network says that it will meet resistance @ 3.00, but if it breaks through its going to go to 4.00 or higher just prior to approval.

I hope its the latter.

Either way no complaints here.

I think FDA approval is likely.

[adiwrites]

agree...highly likely to get approved..

[Spunk]

There seems to be quite a lot of interest in pumping DDSS these days especially from my fellow canucks; however my money is on APPA. APPA faces headwind to get its price above $1 to clear the Nasdaq hurdle in up coming weeks. I will be waiting and watching.

This would likely be my last post for the year. I would take this opportunity to thank the team behind FavStocks for a job well done. Happy holidays and may the trading gods be nice to us in 2010!

Good call on APPA ....its up over 50%

[Lucifer]

There seems to be a little game going on with MNKD's share price these days. Every time it touches above $9, some analyst will publish a negative report to trigger weak hand panic selling. And every time there is strong buying pressure at $7.50 to propel the share price back up.

I am not smart enough to figure out who is manipulating the market for whose benefit. All I know is that buying below $8 before the approval date seems like a low risk short term play going forward.

[Spunk]

who's intended target, and what is it?

Am hoping for $3.00 prior to approval, which is most likely gonna happen if this stock closes january above 2.68- 2.90 if this happens then expect at lest %30 in the week prior to approval which puts ddss at 3.50- 3.77 US dollars......keeping my fingers crossed on this one approval should see $7 - 12 dollars but with the shelf offering $5 - $9